HH
GSK icon

Hilltop Holdings’s GSK GSK Stock Holding History

Hilltop Holdings’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$367K Sell
6,646
-10,215
-61% -$554K 0.03% 469
2025
Q4 		$827K Sell
16,861
-601
-3% -$28K 0.05% 386
2025
Q3 		$754K Buy
17,462
+4,333
+33% +$169K 0.04% 439
2025
Q2 		$504K Buy
13,129
+3,086
+31% +$118K 0.03% 513
2025
Q1 		$389K Buy
10,043
+1,438
+17% +$52.6K 0.02% 589
2024
Q4 		$291K Buy
8,605
+504
+6% +$18.1K 0.02% 674
2024
Q3 		$331K Buy
+8,101
New +$331K 0.02% 624
2024
Q2 		– Sell
-5,345
Closed -$229K – 636
2024
Q1 		$229K Buy
+5,345
New +$220K 0.02% 570
2023
Q4 		– Sell
-6,155
Closed -$223K – 607
2023
Q3 		$223K Buy
6,155
+43
+0.7% +$1.53K 0.03% 517
2023
Q2 		$218K Sell
6,112
-400
-6% -$14.3K 0.03% 513
2023
Q1 		$232K Buy
+6,512
New +$228K 0.03% 467
2022
Q1 		– Sell
-7,228
Closed -$398K – 579
2021
Q4 		$398K Hold
7,228
– – 0.04% 400
2021
Q3 		$346K Sell
7,228
-720
-9% -$36.2K 0.04% 427
2021
Q2 		$395K Sell
7,948
-7,708
-49% -$370K 0.04% 388
2021
Q1 		$699K Buy
15,656
+7,610
+95% +$345K 0.09% 217
2020
Q4 		$370K Sell
8,046
-3,293
-29% -$151K 0.05% 327
2020
Q3 		$534K Sell
11,339
-1,148
-9% -$57.5K 0.09% 221
2020
Q2 		$637K Sell
12,487
-2,663
-18% -$137K 0.12% 180
2020
Q1 		$717K Sell
15,150
-1,406
-8% -$75K 0.17% 127
2019
Q4 		$973K Sell
16,556
-319
-2% -$17.7K 0.18% 136
2019
Q3 		$900K Buy
16,875
+1,604
+11% +$82.5K 0.17% 138
2019
Q2 		$764K Buy
15,271
+1,051
+7% +$52.7K 0.16% 132
2019
Q1 		$742K Sell
14,220
-737
-5% -$36.8K 0.16% 143
2018
Q4 		$715K Sell
14,957
-6,490
-30% -$320K 0.18% 123
2018
Q3 		$1.08M Sell
21,447
-1,720
-7% -$87.4K 0.23% 115
2018
Q2 		$1.17M Buy
23,167
+872
+4% +$43.9K 0.25% 106
2018
Q1 		$1.09M Sell
22,295
-36,053
-62% -$1.68M 0.19% 127
2017
Q4 		$2.59M Buy
58,348
+4,088
+8% +$189K 0.58% 36
2017
Q3 		$2.75M Sell
54,260
-1,803
-3% -$91.5K 0.83% 29
2017
Q2 		$3.02M Sell
56,063
-82
-0.1% -$4.37K 0.89% 23
2017
Q1 		$2.96M Sell
56,145
-1,190
-2% -$60.4K 0.89% 23
2016
Q4 		$2.76M Sell
57,335
-6,691
-10% -$331K 0.86% 25
2016
Q3 		$3.45M Sell
64,026
-3,995
-6% -$219K 1.09% 13
2016
Q2 		$3.69M Buy
68,021
+4,117
+6% +$217K 1.17% 14
2016
Q1 		$3.24M Sell
63,904
-4,097
-6% -$204K 1.01% 19
2015
Q4 		$3.43M Buy
68,001
+1,453
+2% +$74.1K 1% 17
2015
Q3 		$3.2M Buy
66,548
+7,694
+13% +$401K 0.94% 19
2015
Q2 		$3.06M Sell
58,854
-324
-0.5% -$18.2K 0.83% 18
2015
Q1 		$3.41M Buy
59,178
+41,242
+230% +$2.36M 0.87% 20
2014
Q4 		$958K Buy
17,936
+626
+4% +$35K 0.33% 77
2014
Q3 		$995K Buy
17,310
+3,863
+29% +$237K 0.46% 75
2014
Q2 		$898K Buy
13,447
+3,777
+39% +$256K 0.42% 77
2014
Q1 		$645K Buy
9,670
+5,858
+154% +$396K 0.32% 87
2013
Q4 		$254K Buy
+3,812
New +$247K 0.13% 190

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hilltop Holdings's GSK Position: Q1 2026 in Review

Hilltop Holdings reduced its GSK (GSK) stake by 61% in Q1 2026, selling an estimated $554K and leaving 6,646 shares worth $367K. The position accounts for 0.03% of the portfolio, ranked #469.

Hilltop Holdings first reported a position in GSK in Q4 2013 and has held it in 44 quarters since. The position peaked at $3.69M in Q2 2016. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Hilltop Holdings held 6,646 shares of GSK worth $367K as of Q1 2026.
  • Hilltop Holdings sold 10,215 GSK shares in Q1 2026, an estimated $554K.
  • GSK made up 0.03% of Hilltop Holdings's portfolio in Q1 2026, its #469 holding.
  • Hilltop Holdings first reported a position in GSK in Q4 2013 and has held it in 44 quarters since.
  • Hilltop Holdings's GSK position peaked at $3.69M in Q2 2016.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.